by Caltron Clays | Feb 19, 2026 | Pharmaceutical Materials
Introduction: The global joint health supplement market is undergoing a structural transformation. Nutraceutical manufacturers are no longer satisfied with single-ingredient formulations that target only one pathway of cartilage support. Instead, the industry is...
by Caltron Clays | Feb 14, 2026 | Pharmaceutical Materials
Introduction: Calcium deficiency remains one of the most persistent global micronutrient challenges despite decades of supplementation efforts. Across Asia, Europe, North America, and emerging economies, inadequate calcium intake continues to affect bone density,...
by Caltron Clays | Feb 10, 2026 | Pharmaceutical Materials
Introduction: Calcium remains one of the most researched and widely consumed minerals in human nutrition, yet calcium deficiency continues to affect populations across age groups worldwide. From inadequate bone development in children to accelerated bone loss in...
by Caltron Clays | Feb 5, 2026 | Pharmaceutical Materials
Introduction: The Global Shift Toward Natural, High-Absorption Calcium Sources The global pharmaceutical and nutraceutical landscape is witnessing a decisive shift in mineral nutrition strategy. Calcium supplementation, once dominated by commodity-grade mined calcium...
by Caltron Clays | Feb 3, 2026 | Pharmaceutical Materials
Introduction: The Evolution of Calcium in Modern Nutrition Calcium supplementation has evolved far beyond basic mineral fortification. As global nutraceutical and pharmaceutical markets mature, brands are shifting their focus from elemental calcium content to how...
by Caltron Clays | Jan 29, 2026 | Pharmaceutical Materials
Introduction – The New Wave of Sustainability in Nutraceutical Manufacturing The global nutraceutical and pharmaceutical industries are undergoing a structural transformation. Sustainability is no longer a supporting claim it has become a core decision-making factor...
Recent Comments